Search results
One AstraZeneca Insider Raised Stake By 50% In Previous Year
Simply Wall St. via Yahoo Finance UK· 2 hours agoViewing insider transactions for AstraZeneca PLC's (LON:AZN ) over the last year, we see that...
AstraZeneca trial fails to treat 'challenging' breast cancer
ShareCast· 3 hours agoAstraZeneca announced on Tuesday that the phase three ‘CAPItello-290’ trial for ‘Truqap’, or...
Astrazeneca (AZN) Stock Sinks As Market Gains: Here's Why
Zacks via Yahoo Finance UK· 14 hours agoAstrazeneca (AZN) closed at $79.31 in the latest trading session, marking a -0.35% move from the...
AstraZeneca's breast cancer drug combination fails in late-stage trial
Reuters· 5 hours ago, opens new tab said on Tuesday its breast cancer drug, Truqap, in combination with chemotherapy...
AstraZeneca's (AZN) Imfinzi Gets FDA Nod in Expanded Use
Zacks via Yahoo Finance UK· 20 hours agoThe FDA approves AstraZeneca's (AZN) Imfinzi in combination with chemotherapy for treating mismatch...
AstraZeneca lung cancer drug approved in the US
This Is Money· 1 day agoAstraZeneca revealed that US Food and Drug Administration has approved its lung cancer drug alongside other chemotherapy treatment. In a statement,...
Astrazeneca drug gets US approval for use on endometrial cancer
CityAM via Yahoo Finance UK· 1 day agoA company logo is seen at the AstraZeneca HQ Astrazeneca’s Imfinzi drug has been approved in the US...
AstraZeneca's Imfinzi gets US approval for endometrial cancer patients
ShareCast· 1 day agoAstraZeneca said its Imfinzi cancer treatment had been approved in the US as treatment for adult patients with primary advanced or recurrent endometrial cancer.
Astra Drug Doesn’t Help Patients With Tough Cancer Live Longer
Bloomberg· 5 hours agoAstraZeneca Plc’s new medicine Truqap didn’t help patients with a hard-to-treat form of breast...
BUSINESS LIVE: Ashtead Group posts record profits
This Is Money· 5 hours agoAmong the companies with reports and trading updates today are Ashtead Group, Whitbread, SThree, AstraZeneca, Woodside Energy and Melrose Group. UBS will...